论文部分内容阅读
异搏定(Verapamil)是慢通道阻滞剂中研究最广泛的药物之一,1962年Haas引用于临床,是治疗心血管疾病及心脏复苏的新药,具有保护缺血心肌,扩张血管,抗心律失常和心绞痛等作用。从临床疗效来看,异搏定在心脏急救治疗中是一个有效的药
Verapamil is one of the most widely studied drugs in slow channel blockers. In 1962, Haas was cited as a new drug for the treatment of cardiovascular diseases and cardiopulmonary resuscitation. It has the functions of protecting ischemic myocardium, dilating blood vessels, Disorders and angina and other effects. From the clinical point of view, Verapamil is an effective drug in cardiac emergency treatment